Tassinari D - Search Results

1

Transdermal opioids as front line treatment of moderate to severe cancer pain: a systemic review.

Tassinari D, Drudi F, Rosati M, Maltoni M. Tassinari D, et al. Palliat Med. 2011 Jul;25(5):478-87. doi: 10.1177/0269216311404274. Palliat Med. 2011. PMID: 21708854 Review.

2

Adverse effects of transdermal opiates treating moderate-severe cancer pain in comparison to long-acting morphine: a meta-analysis and systematic review of the literature.

Tassinari D, Sartori S, Tamburini E, Scarpi E, Raffaeli W, Tombesi P, Maltoni M. Tassinari D, et al. J Palliat Med. 2008 Apr;11(3):492-501. doi: 10.1089/jpm.2007.0200. J Palliat Med. 2008. PMID: 18363493 Review.

3

Transdermal fentanyl as a front-line approach to moderate-severe pain: a meta-analysis of randomized clinical trials.

Tassinari D, Sartori S, Tamburini E, Scarpi E, Tombesi P, Santelmo C, Maltoni M. Tassinari D, et al. J Palliat Care. 2009 Autumn;25(3):172-80. J Palliat Care. 2009. PMID: 19824278

4

[Transdermal opiates in the treatment of moderate-severe cancer pain. Recommendations for clinical practice].

Tassinari D, Drudi F, Carloni F, Castellani C, Scarpi E, Maltoni M. Tassinari D, et al. Recenti Prog Med. 2009 Dec;100(12):551-8. Recenti Prog Med. 2009. PMID: 20178309 Review. Italian.

5

The second step of the analgesic ladder and oral tramadol in the treatment of mild to moderate cancer pain: a systematic review.

Tassinari D, Drudi F, Rosati M, Tombesi P, Sartori S, Maltoni M. Tassinari D, et al. Palliat Med. 2011 Jul;25(5):410-23. doi: 10.1177/0269216311405090. Palliat Med. 2011. PMID: 21708849 Review.

6

Prognostic assessment in terminally ill cancer patients: from evidence-based knowledge to a patient-physician relationship and back.

Maltoni M, Tassinari D. Maltoni M, et al. Among authors: tassinari d. Palliat Med. 2004 Jan;18(1):77-9. doi: 10.1191/0269216304pm868xx. Palliat Med. 2004. PMID: 14982216 No abstract available.

7

The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy.

Tassinari D, Montanari L, Maltoni M, Ballardini M, Piancastelli A, Musi M, Porzio G, Minotti V, Caraceni A, Poggi B, Stella A, Aielli F, Scarpi E. Tassinari D, et al. Support Care Cancer. 2008 Apr;16(4):359-70. doi: 10.1007/s00520-007-0302-3. Epub 2007 Jul 13. Support Care Cancer. 2008. PMID: 17629751

8

[Neuropathic pain in oncology. Novel evidence for clinical practice].

Tassinari D, Drudi F, Carloni F, Possenti C, Santelmo C, Castellani C. Tassinari D, et al. Recenti Prog Med. 2011 May;102(5):220-7. doi: 10.1701/659.7673. Recenti Prog Med. 2011. PMID: 21607008 Review. Italian.

9

Bevacizumab in the treatment of advanced, non-squamous non-small cell lung cancer: an evidence-based approach.

Tassinari D, Sartori S, Papi M, Drudi F, Castellani C, Carloni F, Tombesi P, Lazzari-Agli L. Tassinari D, et al. Oncology. 2011;80(5-6):350-8. doi: 10.1159/000328781. Epub 2011 Jul 27. Oncology. 2011. PMID: 21791945

10

Noninferiority trials in second-line treatments of nonsmall cell lung cancer: a systematic review of literature with meta-analysis of phase III randomized clinical trials.

Tassinari D, Scarpi E, Sartori S, Drudi F, Castellani C, Carloni F, Tombesi P, Lazzari-Agli L. Tassinari D, et al. Am J Clin Oncol. 2012 Dec;35(6):593-9. doi: 10.1097/COC.0b013e31822dfd13. Am J Clin Oncol. 2012. PMID: 21926899 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters